T1 weighted imaging pre-post contrast Delta T1 quantification differentiates perfused and non-perfused regions of tumor tissue and allows for monitoring of tumor changes in patients treated with...
QMENTA News
QMENTA Appoints Rob Bancroft as New Chief Executive Officer Paulo Rodrigues Takes the Helm as Chief Technology Officer Barcelona, Spain. Release: January 22, 2020. For Immediate Release. QMENTA,...
Top 5 Imaging Trends From ECTRIMS 2019 by Pablo Villoslada, MD, PhD. The world’s largest meeting on Multiple Sclerosis, ECTRIMS 2019, took place in Stockholm, Sweden. This article reviews the major...
QMENTA is pleased to be collaborating with Harvard’s the Athinoula A. Martinos Center for Biomedical Imaging and the University of Rochester in supporting an exciting research challenge open to image...
QMENTA’s Quality Management System (QMS) is a company-wide new initiative, which has enhanced the quality of our products & services and improved our system on patient safety. We have...
BOSTON, MA, February 6th 2019 – QMENTA – the data-driven, AI-powered company, that aims to revolutionize the way medical imaging is used in clinical trials and clinical care – welcomes Pablo...
We are proud to announce that we will be exhibiting at: ECTRIMS in Berlin from October 10th to October 12th, booth C12 RSNA in Chicago from November 25th to November 30th, booth 7665 PCT in Barcelona...
BOSTON, MA & CAMBRIDGE, MA – QMENTA and Amylyx Pharmaceuticals today announced a collaboration to support Amylyx’s upcoming clinical trial of AMX0035 in Alzheimer’s disease. QMENTA will use its...
A poor functional outcome of stroke patients may be predicted by early signs on CT and MRI. Radiology exams carried out within 6 hours after stroke onset can contain important insights supporting the...
Impact of psychiatric disorders in the world. The World Health Organization estimates that around 450 million people suffer from psychiatric disorders. They predict that one in four people in the...